Skip to main content

Feature

CEBS to continue to prioritise work surrounding CRD

The Committee of European Banking Supervisors (CEBS) has published its annual report for 2005, in which it outlines areas of ongoing work and priorities for the remainder of this year. According to the report, the “main focus of the Committee’s work in…

Deutsche Bank looks east

German investment bank Deutsche Bank has launched two new structured products with exposure to Japanese and East Asia equities. The Protected Nikkei and the Protected Far East offer participation in the respective equity markets and 100% capital…

Abbey hires head of intermediary business

Abbey Financial Markets has hired Gary Dale as head of business development for its UK and offshore IFA, private banking and partnership channels. Dale will build on external distributions links through life and pensions partners as well as other…

CEBS seeks comments on stress testing

The Committee of European Banking Supervisors (CEBS) has begun a consultation on technical guidance for stress testing under the Capital Requirements Directive (CRD). CP12 will aim to provide additional technical guidance to regulators, and complements…

FSA issues consultation paper on regulatory reporting

The Financial Services Authority (FSA) in the UK has issued consultation paper 06/11, Integrating Regulatory Reporting (IIR), for investment managers, securities and futures firms, operators and trustees of collective investment schemes, venture capital…

Jefferies makes further hire in equity structured products

US based investment bank Jefferies has continued to expand its structured products business with the recruitment of Mark O’Donnell as its New York-based head of equity structured products. O'Donnell will partner with Alex Wohl, who recently joined as…

L&G launches protected capital investment plan 3

UK distributor Legal and General (L&G) has launched a new protected capital investment product. Protected Capital Investment Plan 3 pays the greater of a minimum of 22% capital growth or 50% of any FTSE 100 index growth. The product has a term of 6 years…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here